手機版
化工儀器網手機版
化工儀器網小程序
官方微信
公眾號：chem17
掃碼關注視頻號
資料簡介
Virogen是一家專注于為全球科研與診斷市場提供高質量生物試劑的抗體公司。公司由哈佛大學和麻省理工學院（MIT）的科學家團隊創立，依托頂尖學術資源，始終致力于推動生命科學領域的技術創新。
作為行業核心供應商，Virogen的核心產品線涵蓋研究級抗體、高純度抗原及專業實驗室設備三大領域。公司定期擴充產品目錄，通過嚴格的質量控制體系確保試劑在免疫印跡（WB）、免疫組化（IHC）、流式細胞術（Flow Cytometry）等關鍵應用中表現穩定可靠。其特色服務包括定制化抗體/抗原開發和合同研究服務（CRO），可針對客戶特定靶點或實驗需求提供個性化解決方案。
在技術設備方面，Virogen自主研發的HeartBreaker系列組織勻漿器以高效、低損耗的特性成為樣本前處理的重要工具，顯著提升實驗可重復性。公司憑借多語言技術支持團隊（覆蓋英語、西班牙語、中文等）構建了全球服務體系，服務網絡遍及北美、歐洲、亞洲等多個研究重鎮，助力跨國科研協作。
Virogen深耕傳染病、癌癥生物標志物、神經科學等熱點領域，其試劑廣泛應用于疫苗開發、疾病機制研究和體外診斷（IVD）產品研發。公司堅持"以科學家服務科學家"的理念，通過優化供應鏈管理提供高性價比產品，同時推出定期活動（Deal Offerings），降低科研成本門檻。
特別告知：為保證產品質量與良好性能，所以在購買相應產品的同時我司會收取一定量的運輸費用！！！本次報價有效時間為2025年6月26日---2025年12月14日。
（*此為部分產品價格,完整價格請下載文件）
貨號 | 品名 | 規格 | 價格 | 品牌 |
00211-V-100ug | HHV-4 recombinant p18 antigen Region: 1-119aa | 100ug/vial | 3000.00 | Virogen |
00212-V-100ug | HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa | 100ug/vial | 3000.00 | Virogen |
00213-V-100ug | HHV-4 recombinant EA antigen. Region: 306-390aa | 100ug/vial | 3000.00 | Virogen |
00167-V-100ug | HDV Ag recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00214-V-100ug | Tick-born encephalitis virus gE recombinant antigen | 100ug/vial | 3000.00 | Virogen |
01005-V-100ug | Chlamydia trachomatis PDP3-D, Full length recombinant | 100ug/vial | 3000.00 | Virogen |
01011-V-100ug | Chlamydia trachomatis MOMP Recombinant antigen with out transmembrane domain. | 100ug/vial | 3000.00 | Virogen |
00206-V-100ug | Toxoplasma gondii MIC 3 recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00207-V-100ug | Toxoplasma gondii P24 (GRA1) recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00208-V-100ug | Toxoplasma gondii P29 (GRA7) recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00209-V-100ug | Toxoplasma gondii P30 (SAG1) recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00111-V-100ug | HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa | 100ug/vial | 3000.00 | Virogen |
00112-V-100ug | HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa | 100ug/vial | 3000.00 | Virogen |
00113-V-100ug | HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa | 100ug/vial | 3000.00 | Virogen |
00114-V-100ug | HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa | 100ug/vial | 3000.00 | Virogen |
00168-V-100ug | HIV-1 p17/24/gp120-gp41 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00169-V-100ug | HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | 100ug/vial | 3000.00 | Virogen |
00170-V-100ug | HIV-1 gp41 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00171-V-100ug | HIV-1 gp41 Long recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00172-V-100ug | HIV-1 p17-p24 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00173-V-100ug | HIV-2 gp32 recombinant antigen. . | 100ug/vial | 3000.00 | Virogen |
00174-V-100ug | HIV-1 p24 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00175-V-100ug | HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. | 100ug/vial | 3000.00 | Virogen |
00176-V-100ug | HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. | 100ug/vial | 3000.00 | Virogen |
00177-V-100ug | HIV 1 p24 core recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00178-V-100ug | HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | 100ug/vial | 3000.00 | Virogen |
00179-V-100ug | HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. | 100ug/vial | 3000.00 | Virogen |
00110-V-100ug | HIV-1 tat recombinant antigen full length 15 kDa | 100ug/vial | 3000.00 | Virogen |
00180-V-100ug | HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. | 100ug/vial | 3000.00 | Virogen |
00198-V-100ug | HIV-1 reverse transcriptase recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00199-V-100ug | HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). | 100ug/vial | 3000.00 | Virogen |
00115-V-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa | 100ug/vial | 3000.00 | Virogen |
00115-V-B-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. | 100ug/vial | 3000.00 | Virogen |
00115-V-F-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. | 100ug/vial | 3000.00 | Virogen |
00115-V-R-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. | 100ug/vial | 3000.00 | Virogen |
00116-V-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. | 100ug/vial | 3000.00 | Virogen |
00116-V-B-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. | 100ug/vial | 3000.00 | Virogen |
00116-V-F-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. | 100ug/vial | 3000.00 | Virogen |
00116-V-R-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. | 100ug/vial | 3000.00 | Virogen |
00117-V-100ug | HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | 100ug/vial | 3000.00 | Virogen |
00150-V-100ug | HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a | 100ug/vial | 3000.00 | Virogen |
00151-V-100ug | HCV core 24 antigen. | 100ug/vial | 3000.00 | Virogen |
00152-V-100ug | HCV core recombinant antigen a.a.105-302 | 100ug/vial | 3000.00 | Virogen |
00153-V-100ug | HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a | 100ug/vial | 3000.00 | Virogen |
00154-V-100ug | HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 | 100ug/vial | 3000.00 | Virogen |
00155-V-100ug | HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. | 100ug/vial | 3000.00 | Virogen |
00156-V-100ug | HCV NS4 1916-1947aa recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00157-V-100ug | HCV NS5 2061-2302aa recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00158-V-100ug | HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. | 100ug/vial | 3000.00 | Virogen |
00120-V-100ug | HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa | 100ug/vial | 3000.00 | Virogen |
00121-V-100ug | HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa | 100ug/vial | 3000.00 | Virogen |
00122-V-100ug | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant | 100ug/vial | 3000.00 | Virogen |
00123-V-100ug | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity | 100ug/vial | 3000.00 | Virogen |
00124-V-100ug | HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant | 100ug/vial | 3000.00 | Virogen |
00131-V-100ug | HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. | 100ug/vial | 3000.00 | Virogen |
00132-V-100ug | HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. | 100ug/vial | 3000.00 | Virogen |
00133-V-100ug | HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. | 100ug/vial | 3000.00 | Virogen |
00141-V-100ug | T. Pallidum recombinant antigen p15 (full length) | 100ug/vial | 3000.00 | Virogen |
00142-V-100ug | T. Pallidum recombinant antigen p17 (full length) | 100ug/vial | 3000.00 | Virogen |
00143-V-100ug | T. Pallidum recombinant antigen p45 (full length) | 100ug/vial | 3000.00 | Virogen |
00144-V-100ug | T. Pallidum recombinant antigen TmpA (full length) | 100ug/vial | 3000.00 | Virogen |
00185-V-100ug | CMV Pp65 (UL83) recombinant antigen , full length | 100ug/vial | 3000.00 | Virogen |
00188-V-100ug | CMV Pp65 (UL83) recombinant antigen a.a. 297-510 | 100ug/vial | 3000.00 | Virogen |
00189-V-100ug | CMV Pp52 (UL44) recombinant antigen a.a. 271-428 | 100ug/vial | 3000.00 | Virogen |
00187-V-100ug | CMV gB-AD1 (UL55) recombinant antigen a.a. 549-645 | 100ug/vial | 3000.00 | Virogen |
00186-V-100ug | CMV Pp150 recombinant antigen a.a. 426-606 | 100ug/vial | 3000.00 | Virogen |
00159-V-100ug | HAV VP1-P2A recombinant antigen a.a. 722-830. | 100ug/vial | 3000.00 | Virogen |
00160-V-100ug | HAV VP4-VP2 recombinant antigen a.a. 55-164. | 100ug/vial | 3000.00 | Virogen |
00161-V-100ug | HAV P2C-P3A recombinant antigen a.a. 1492-1606. | 100ug/vial | 3000.00 | Virogen |
00162-V-100ug | HAV P3C recombinant antigen a.a. 1643-1743. | 100ug/vial | 3000.00 | Virogen |
00163-V-100ug | HAV VP3 recombinant antigen a.a. 304-415. | 100ug/vial | 3000.00 | Virogen |
00164-V-100ug | HAV VP1-P2A recombinant antigen a.a. 669-782. | 100ug/vial | 3000.00 | Virogen |
00165-V-100ug | HAV HAV P2C recombinant antigen a.a. 1121-1234. | 100ug/vial | 3000.00 | Virogen |
00166-V-100ug | HAV P2C-P3A recombinant antigen a.a. 1392-1521. | 100ug/vial | 3000.00 | Virogen |
00181-V-100ug | HSV-1 gD recombinant antigen a.a. 266-394. | 100ug/vial | 3000.00 | Virogen |
00182-V-100ug | HSV-2 gD recombinant antigen a.a. 266-394. | 100ug/vial | 3000.00 | Virogen |
00183-V-100ug | HSV-2 gD recombinant antigen a.a. 525-578. | 100ug/vial | 3000.00 | Virogen |
00184-V-100ug | HSV-1 gD recombinant antigen a.a. 84-175. | 100ug/vial | 3000.00 | Virogen |
1131-V-100ug | HSV-2 gB recombinant antigen | 100ug/vial | 3000.00 | Virogen |
1140-V-100ug | E. coli recombinant HSV II gG antigen. Immunodominant Region: a.a. 525-578 | 100ug/vial | 3000.00 | Virogen |
00203-V-100ug | HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. | 100ug/vial | 3000.00 | Virogen |
00204-V-100ug | HLTV-I p24 core recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00205-V-100ug | HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. | 100ug/vial | 3000.00 | Virogen |
00700-V-100ug | HTLV-1 gp21 recombinant protein | 100ug/vial | 3000.00 | Virogen |
00701-V-100ug | HTLV-1 gp46 recombinant protein | 100ug/vial | 3000.00 | Virogen |
00215-V-100ug | Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. | 100ug/vial | 3000.00 | Virogen |
00216-V-100ug | Rubella virus E2 recombinant antigen a.a. 31-105. | 100ug/vial | 3000.00 | Virogen |
00217-V-100ug | Rubella virus capsid (C) recombinant antigen a.a. 1-123. | 100ug/vial | 3000.00 | Virogen |
00191-V-100ug | SARS-Associated Coronavirus E recombinant antigen a.a. 1-76. | 100ug/vial | 3000.00 | Virogen |
00192-V-100ug | SARS-Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1-49. | 100ug/vial | 3000.00 | Virogen |
00193-V-100ug | SARS-Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340-390. | 100ug/vial | 3000.00 | Virogen |
00194-V-100ug | SARS-Associated Coronavirus M recombinant antigen a.a. 182-216. | 100ug/vial | 3000.00 | Virogen |
00195-V-100ug | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. | 100ug/vial | 3000.00 | Virogen |
00196-V-100ug | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. | 100ug/vial | 3000.00 | Virogen |
00197-V-100ug | SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. | 100ug/vial | 3000.00 | Virogen |
00200-V-100ug | VZV gE recombinant antigen a.a. 48-135. | 100ug/vial | 3000.00 | Virogen |
00201-V-100ug | VZV ORF9 recombinant antigen a.a. 6-28/76-100. | 100ug/vial | 3000.00 | Virogen |
00202-V-100ug | VZV ORF26 recombinant antigen a.a. 9-33/184-208. | 100ug/vial | 3000.00 | Virogen |
00401-V-100ug | West Nile Virus Envelope recombinant antigen-Immunodominant region | 100ug/vial | 3000.00 | Virogen |
00402-V-100ug | West Nile Virus Pre-M recombinant antigen-Immunodominant region | 100ug/vial | 3000.00 | Virogen |
00403-V-100ug | West Nile Virus Envelope full length recombinant antigen 42 kDa region | 100ug/vial | 3000.00 | Virogen |
00345-V-100ug | Zika Virus ENV -NS1 fusion antigen 54 kDa | 100ug/vial | 3000.00 | Virogen |
00346-V-100ug | Zika Virus NS1 antigen 34 kDa | 100ug/vial | 3000.00 | Virogen |
00347-V-100ug | H. pylori CogA antigen 34 kDa | 100ug/vial | 3000.00 | Virogen |
00321-V-100ug | Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 | 100ug/vial | 3000.00 | Virogen |
1170-V-100ug | Human Endogenous Retrovirus Envelope antigen 48 kDa | 100ug/vial | 3000.00 | Virogen |
3001-V-100ug | Prostatic pacid hosphatase - full length (human) | 100ug/vial | 3000.00 | Virogen |
3002-V-100ug | Ovine Prolactin | 100ug/vial | 3000.00 | Virogen |
00820-V-100ug | MPXV A29 (recombinant), partial., a.a. 1-110. pI/Mw: 6.44 / 13382.09 | 100ug/vial | 3000.00 | Virogen |
00821-V-100ug | MPXV A27 (recombinant), partial., a.a. 1-110. MW: ~14 kDa | 100ug/vial | 3000.00 | Virogen |
00900-V-100ug | Phospholipase A2 P00630 Bee Venom Recombinant Protein | 100ug/vial | 3000.00 | Virogen |
00901-V-100ug | Soy Bean p34 Recombinant protein | 100ug/vial | 3000.00 | Virogen |
900-V-100ug | Dermatophagoides farina Der F1 antigen (recombinant). Full length. Non enzymatically active. | 100ug/vial | 3000.00 | Virogen |
901-V-100ug | Dermatophagoides pteronyssinus Der P1 antigen . Full length. Non enzymatically active. | 100ug/vial | 3000.00 | Virogen |
012-A-100ug | anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
013-A-100ug | anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
014-A-100ug | anti-HIV-1 p17 IgG1 (monoclonal) Produced against a recombinant protein | 100ug/vial | 3000.00 | Virogen |
0114-A-100ug | anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
015-A-100ug | anti-HIV-1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
016-A-100ug | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
017-A-100ug | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
018-A-100ug | anti-HCV NS4 IgG2a (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
020-A-100ug | anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate | 100ug/vial | 3000.00 | Virogen |
021-A-100ug | anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. | 100ug/vial | 3000.00 | Virogen |
022-A-100ug | anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. | 100ug/vial | 3000.00 | Virogen |
023-A-100ug | anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. | 100ug/vial | 3000.00 | Virogen |
024-A-100ug | anti-HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. | 100ug/vial | 3000.00 | Virogen |
025-A-100ug | anti-Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus | 100ug/vial | 3000.00 | Virogen |
026-A-100ug | anti-Adenovirus C11 IgG2a (monoclonal) Produced against purified Ad7 virus | 100ug/vial | 3000.00 | Virogen |
027-A-100ug | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 100ug/vial | 3000.00 | Virogen |
028-A-100ug | anti-TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. | 100ug/vial | 3000.00 | Virogen |
030-A-100ug | anti-HBcAg core IgM (monoclonal) Produced against recombinant HBcAg core antigen. | 100ug/vial | 3000.00 | Virogen |
031-A-100ug | anti-HBsAg pre-surface IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 100ug/vial | 3000.00 | Virogen |
032-A-100ug | anti-HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 100ug/vial | 3000.00 | Virogen |
033-A-100ug | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 70 – 80 a.a. | 100ug/vial | 3000.00 | Virogen |
034-A-100ug | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 135-140 a.a. | 100ug/vial | 3000.00 | Virogen |
035-A-100ug | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope:141-154 a.a. | 100ug/vial | 3000.00 | Virogen |
036-A-100ug | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 1-10 a.a. | 100ug/vial | 3000.00 | Virogen |
037-A-100ug | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 138- 145 a.a. | 100ug/vial | 3000.00 | Virogen |
038-A-100ug | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 130-140 a.a. | 100ug/vial | 3000.00 | Virogen |
0116-A-100ug | anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 100ug/vial | 3000.00 | Virogen |
0117-A-100ug | anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 100ug/vial | 3000.00 | Virogen |
216-A-100ug | anti-HCV core IgG1 (monoclonal)Produced against recombinant antigen | 100ug/vial | 3000.00 | Virogen |
245-A-100ug | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 | 100ug/vial | 3000.00 | Virogen |
246-A-100ug | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen | 100ug/vial | 3000.00 | Virogen |
247-A-100ug | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 | 100ug/vial | 3000.00 | Virogen |
266-A-100ug | anti-HCV NS5b rabbit (polycnonal)Produced against a recombinant protein | 100ug/vial | 3000.00 | Virogen |
199-A-100ug | anti-HCV NS5a rabbit (polycnonal) Produced against a recombinant protein | 100ug/vial | 3000.00 | Virogen |
276-A-100ug | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 100ug/vial | 3000.00 | Virogen |
010-A-100ug | anti-Rabies G antigen monoclonal antibody. Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
111-A-100ug | anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
101-A-100ug | anti-Glutathione monoclonal antibody IgG1 | 100ug/vial | 3000.00 | Virogen |
102-A-100ug | anti-Cysteine monoclonal antibody IgG1 | 100ug/vial | 3000.00 | Virogen |
105-A-100ug | anti-Ergothioneine rabbit polyclonal antibody | 100ug/vial | 3000.00 | Virogen |
041-A-100ug | anti-Thyroxine monoclonal antibody IgG2a | 100ug/vial | 3000.00 | Virogen |
011-A-100ug | anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. | 100ug/vial | 3000.00 | Virogen |
019-A-100ug | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
029-A-100ug | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
039-A-100ug | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
049-A-100ug | anti-FAS IgM (monoclonal) | 100ug/vial | 3000.00 | Virogen |
059-A-100ug | anti-SLAM anti-CDw150 IgG2a (monoclonal) Produced against an activated B cell line. | 100ug/vial | 3000.00 | Virogen |
069-A-100ug | anti-CD37 IgG2b (monoclonal) Produced against a B cell line. | 100ug/vial | 3000.00 | Virogen |
079-A-100ug | anti-Nuclear Antigen (Proliferating Cells) IgM (monoclonal) Produced against a proliferating Harvey cell line. | 100ug/vial | 3000.00 | Virogen |
066-A-100ug | anti-p53, clone BP53-12 | 100ug/vial | 3000.00 | Virogen |
060-A-100ug | anti-CD3 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
061-A-100ug | anti-CD4 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
062-A-100ug | anti-CD8 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
063-A-100ug | anti-CD16 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
064-A-100ug | anti-CD20 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
065-A-100ug | anti-CD22 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
067-A-100ug | anti-CD45 RA IgG2 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
068-A-100ug | anti-CD54 IgG2b-k monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
071-A-100ug | anti-CD19 IgG1 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
089-A-100ug | anti-CD66e IgG1 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
501-A-100ug | anti-CD3 T-cell | 100ug/vial | 3000.00 | Virogen |
502-A-100ug | anti-CD4 T helper cells | 100ug/vial | 3000.00 | Virogen |
503-A-100ug | anti-CD5 All T-cells | 100ug/vial | 3000.00 | Virogen |
504-A -100ug | anti-CD7 All T-cells | 100ug/vial | 3000.00 | Virogen |
505-A -100ug | anti-CD8 T cytotoxic/supressor cells | 100ug/vial | 3000.00 | Virogen |
506-A -100ug | anti-CD10 Lymphoblasts | 100ug/vial | 3000.00 | Virogen |
507-A -100ug | anti-CD16 NK-cells, monocytes, granulocytes | 100ug/vial | 3000.00 | Virogen |
508-A -100ug | anti-CD18 Leucocytes | 100ug/vial | 3000.00 | Virogen |
509-A-100ug | anti-CD20 B-lymphocytes | 100ug/vial | 3000.00 | Virogen |
510-A-100ug | anti-CD22 B-lymphocytes | 100ug/vial | 3000.00 | Virogen |
511-A-100ug | anti-CD25 IL-2 receptor expressed on activated T and B cells | 100ug/vial | 3000.00 | Virogen |
512-A-100ug | anti-CD26 Activated T, B lymphocytes and macrophages | 100ug/vial | 3000.00 | Virogen |
513-A-100ug | anti-CD34 Hematopoietic precursor cells | 100ug/vial | 3000.00 | Virogen |
514-A-100ug | anti-CD38 Hematopoietic precursors, thymocytes, activated T-cells, plasma cells | 100ug/vial | 3000.00 | Virogen |
515-A-100ug | anti-CD45 Leukocytes | 100ug/vial | 3000.00 | Virogen |
516-A-100ug | anti-CD45 RA B-cells, T-cells, NK-cells | 100ug/vial | 3000.00 | Virogen |
517-A-100ug | anti-ICAM-3, Leukocytes | 100ug/vial | 3000.00 | Virogen |
518-A-100ug | anti-Transferrin receptor on activated T-B-, cells | 100ug/vial | 3000.00 | Virogen |
519-A-100ug | anti-FAS antigen | 100ug/vial | 3000.00 | Virogen |
520-A-100ug | anti-HLA-DR | 100ug/vial | 3000.00 | Virogen |
521-A-100ug | anti-HLA-ABC on all Leukocytes | 100ug/vial | 3000.00 | Virogen |
522-A-100ug | anti-IgM Heavy chain expressed on B cells | 100ug/vial | 3000.00 | Virogen |
523-A-100ug | anti-Cortical thymocytes | 100ug/vial | 3000.00 | Virogen |
131-A-100ug | anti-RhoD human antigen IgG1 | 100ug/vial | 3000.00 | Virogen |
132-A-100ug | anti-A1, A2 human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
133-A-100ug | anti-A1, A2, A3 human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
134-A-100ug | anti-B human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
135-A-100ug | anti-AB human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
136-A-100ug | anti-Rh(o)D human antigen IgM | 100ug/vial | 3000.00 | Virogen |
137-A-100ug | anti-Rh(o)D and Rh(o)Dii human Rhesus system antigen IgG1 | 100ug/vial | 3000.00 | Virogen |
138-A-100ug | anti-RhoC human Rhesus system antigen IgM | 100ug/vial | 3000.00 | Virogen |
139-A-100ug | anti-A1, A2 human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
140-A-100ug | anti-B human blood group antigen IgM | 100ug/vial | 3000.00 | Virogen |
141-A-100ug | anti-H n/ab human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
142-A-100ug | anti-H ab human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
143-A-100ug | anti-H inh human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
144-A-100ug | anti-M human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
145-A-100ug | anti-N human blood antigen Ig2b | 100ug/vial | 3000.00 | Virogen |
146-A-100ug | Antiglobulin (COOMBS) Rabbit polyclonal | 100ug/vial | 3000.00 | Virogen |
109-E | E. coli extract | 100ug/vial | 3000.00 | Virogen |
相關產品
免責聲明
- 凡本網注明“來源：化工儀器網”的所有作品，均為浙江興旺寶明通網絡有限公司-化工儀器網合法擁有版權或有權使用的作品，未經本網授權不得轉載、摘編或利用其他方式使用上述作品。已經本網授權使用作品的，應在授權范圍內使用，并注明“來源：化工儀器網”。違反上述聲明者，本網將追究其相關法律責任。
- 本網轉載并注明自其他來源（非化工儀器網）的作品，目的在于傳遞更多信息，并不代表本網贊同其觀點和對其真實性負責，不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時，必須保留本網注明的作品第一來源，并自負版權等法律責任。
- 如涉及作品內容、版權等問題，請在作品發表之日起一周內與本網聯系，否則視為放棄相關權利。
采購中心